IvelinRadkov/iStock via Getty Images
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy.
After one year of continuous treatment, participants showed not only a halt in disease progression, but also measurable improvements compared to their
Key Points Interested in Cohen & Steers Inc? Here are five stocks we like better. Cohen & Steers posted stronger...
Esther Perel has spent her career exploring the complexities of human relationships. Her seminal book, Mating in Captivity, examined the tension between love and desire. Now, the psychotherapist...
The market regulator, Sebi, on Friday eased mutual fund investing by allowing SWP and STP standing instructions for demat holdings...
According to the Zillow lender marketplace, mortgage rates are mixed today. The average 30-year fixed-rate mortgage rose by 3 basis...
President Donald Trump delivered an address to the nation on July 16 that focused on the insecurity of American federal...
Does the gun control crowd now believe firearms are too expensive and should cost less – thus becoming easier to...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
-1024x609.jpg "President Trump Exposes America’s Election Integrity Disaster")
-1024x669.jpg "Now Even the Left Is Stockpiling Guns and Complaining About Price?")
